

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 4.88573704 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.88573704 |
| 3 | NIK/NF-kappaB signaling (GO:0038061) | 4.82500370 |
| 4 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.45833522 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.45460573 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.37000645 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 4.30144692 |
| 8 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.22321916 |
| 9 | positive regulation of antigen processing and presentation (GO:0002579) | 4.09844518 |
| 10 | response to peptidoglycan (GO:0032494) | 4.09732041 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.99953011 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.99953011 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.99246406 |
| 14 | myeloid dendritic cell differentiation (GO:0043011) | 3.90620394 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 3.82175598 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 3.82175598 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.82175598 |
| 18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.82175598 |
| 19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.82175598 |
| 20 | modulation by symbiont of host immune response (GO:0052553) | 3.82175598 |
| 21 | * response to muramyl dipeptide (GO:0032495) | 3.75420476 |
| 22 | myeloid dendritic cell activation (GO:0001773) | 3.74015480 |
| 23 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.66222938 |
| 24 | cellular response to interleukin-15 (GO:0071350) | 3.60590746 |
| 25 | regulation of antigen processing and presentation (GO:0002577) | 3.60078076 |
| 26 | positive regulation of interleukin-12 production (GO:0032735) | 3.58764067 |
| 27 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.53061337 |
| 28 | positive regulation of heat generation (GO:0031652) | 3.52646841 |
| 29 | cellular response to type I interferon (GO:0071357) | 3.51129414 |
| 30 | type I interferon signaling pathway (GO:0060337) | 3.51129414 |
| 31 | immunoglobulin mediated immune response (GO:0016064) | 3.50741588 |
| 32 | response to type I interferon (GO:0034340) | 3.50504548 |
| 33 | regulation of germinal center formation (GO:0002634) | 3.47021165 |
| 34 | neutrophil activation (GO:0042119) | 3.46564870 |
| 35 | granulocyte activation (GO:0036230) | 3.45108441 |
| 36 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.44385683 |
| 37 | regulation of fever generation (GO:0031620) | 3.42004566 |
| 38 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.39799191 |
| 39 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.36397565 |
| 40 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.36081290 |
| 41 | response to interleukin-15 (GO:0070672) | 3.33393328 |
| 42 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.31941459 |
| 43 | positive regulation of interferon-alpha production (GO:0032727) | 3.30841097 |
| 44 | negative regulation of T cell mediated immunity (GO:0002710) | 3.30612532 |
| 45 | regulation of vitamin metabolic process (GO:0030656) | 3.28711509 |
| 46 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.28226515 |
| 47 | regulation of interferon-alpha production (GO:0032647) | 3.28154653 |
| 48 | negative regulation of innate immune response (GO:0045824) | 3.24653040 |
| 49 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.21770555 |
| 50 | regulation of chronic inflammatory response (GO:0002676) | 3.20443210 |
| 51 | positive regulation of defense response to virus by host (GO:0002230) | 3.19764192 |
| 52 | * lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.18904807 |
| 53 | leukocyte aggregation (GO:0070486) | 3.17923759 |
| 54 | regulation of T-helper cell differentiation (GO:0045622) | 3.15930252 |
| 55 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.15558200 |
| 56 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.15039555 |
| 57 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.14349324 |
| 58 | T-helper 1 type immune response (GO:0042088) | 3.12231638 |
| 59 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.12009433 |
| 60 | T cell differentiation involved in immune response (GO:0002292) | 3.10903966 |
| 61 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.10903966 |
| 62 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.10903966 |
| 63 | macrophage activation involved in immune response (GO:0002281) | 3.09562965 |
| 64 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.09162998 |
| 65 | regulation of interleukin-12 production (GO:0032655) | 3.08501379 |
| 66 | interferon-gamma production (GO:0032609) | 3.07403522 |
| 67 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.07217119 |
| 68 | dendritic cell differentiation (GO:0097028) | 3.06672454 |
| 69 | cellular response to interferon-beta (GO:0035458) | 3.05114307 |
| 70 | monocyte chemotaxis (GO:0002548) | 3.04759962 |
| 71 | positive regulation of humoral immune response (GO:0002922) | 3.01923484 |
| 72 | regulation of immunoglobulin secretion (GO:0051023) | 3.01427566 |
| 73 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.99225538 |
| 74 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.98893346 |
| 75 | regulation of RIG-I signaling pathway (GO:0039535) | 2.97474580 |
| 76 | T cell migration (GO:0072678) | 2.97270668 |
| 77 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.96185989 |
| 78 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.95628982 |
| 79 | T-helper cell differentiation (GO:0042093) | 2.95628982 |
| 80 | positive regulation of interleukin-17 production (GO:0032740) | 2.94899310 |
| 81 | positive regulation of interleukin-2 production (GO:0032743) | 2.94737299 |
| 82 | regulation of defense response to virus by host (GO:0050691) | 2.94557214 |
| 83 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.94498485 |
| 84 | negative regulation of interleukin-6 production (GO:0032715) | 2.92988039 |
| 85 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.92557224 |
| 86 | positive regulation of type 2 immune response (GO:0002830) | 2.92468247 |
| 87 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.91354268 |
| 88 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.91224284 |
| 89 | respiratory burst (GO:0045730) | 2.89977325 |
| 90 | regulation of regulatory T cell differentiation (GO:0045589) | 2.89579294 |
| 91 | germinal center formation (GO:0002467) | 2.89280012 |
| 92 | regulation of gamma-delta T cell activation (GO:0046643) | 2.88989529 |
| 93 | negative regulation of interleukin-1 production (GO:0032692) | 2.88962230 |
| 94 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.88315637 |
| 95 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.88168962 |
| 96 | cellular extravasation (GO:0045123) | 2.87444040 |
| 97 | negative thymic T cell selection (GO:0045060) | 2.86186721 |
| 98 | regulation of chemokine biosynthetic process (GO:0045073) | 2.86119549 |
| 99 | cytokine secretion (GO:0050663) | 2.85778092 |
| 100 | defense response to protozoan (GO:0042832) | 2.85177203 |
| 101 | negative regulation of bone resorption (GO:0045779) | 2.84259565 |
| 102 | response to protozoan (GO:0001562) | 2.84081968 |
| 103 | positive regulation of interferon-gamma production (GO:0032729) | 2.83837293 |
| 104 | response to interferon-beta (GO:0035456) | 2.82650733 |
| 105 | negative regulation of interleukin-12 production (GO:0032695) | 2.82164234 |
| 106 | T cell activation involved in immune response (GO:0002286) | 2.82152992 |
| 107 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.82077537 |
| 108 | regulation of memory T cell differentiation (GO:0043380) | 2.81638200 |
| 109 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.81283504 |
| 110 | regulation of cell killing (GO:0031341) | 2.80570964 |
| 111 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.80418366 |
| 112 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.77946230 |
| 113 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.77873294 |
| 114 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.77873294 |
| 115 | microglial cell activation (GO:0001774) | 2.77594030 |
| 116 | B cell mediated immunity (GO:0019724) | 2.77504461 |
| 117 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.76100270 |
| 118 | myeloid cell activation involved in immune response (GO:0002275) | 2.76089933 |
| 119 | natural killer cell mediated immunity (GO:0002228) | 2.75886978 |
| 120 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.75886978 |
| 121 | negative T cell selection (GO:0043383) | 2.74397693 |
| 122 | tolerance induction (GO:0002507) | 2.73014888 |
| 123 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.72936700 |
| 124 | superoxide anion generation (GO:0042554) | 2.71745507 |
| 125 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.71438627 |
| 126 | leukocyte cell-cell adhesion (GO:0007159) | 2.70478810 |
| 127 | regulation of heat generation (GO:0031650) | 2.69899092 |
| 128 | regulation of T-helper 1 type immune response (GO:0002825) | 2.69709065 |
| 129 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.68784027 |
| 130 | myeloid leukocyte activation (GO:0002274) | 2.68238194 |
| 131 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.67369188 |
| 132 | positive regulation of interferon-beta production (GO:0032728) | 2.65767380 |
| 133 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.65761087 |
| 134 | lymphocyte chemotaxis (GO:0048247) | 2.65128912 |
| 135 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.64953185 |
| 136 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.64602417 |
| 137 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.63080019 |
| 138 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.62658251 |
| 139 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.61755818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.94596383 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.14878565 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.05518566 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.85101088 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.66911072 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.98334764 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.80350678 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.64907970 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.51764630 |
| 10 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.50427692 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.50286173 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.37732128 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.26231620 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.93494749 |
| 15 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.74708770 |
| 16 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.70150950 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.69849993 |
| 18 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.62551647 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.59051243 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.34997163 |
| 21 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.34562861 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.30449380 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.19590915 |
| 24 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.99937420 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.99846895 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.91451380 |
| 27 | * MYB_26560356_Chip-Seq_TH2_Human | 1.90733634 |
| 28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.80999767 |
| 29 | * MAF_26560356_Chip-Seq_TH1_Human | 1.78139298 |
| 30 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.77678892 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.70904778 |
| 32 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.64717660 |
| 33 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.61293218 |
| 34 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.60473239 |
| 35 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.59171573 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 1.58776570 |
| 37 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.58343691 |
| 38 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.53749820 |
| 39 | * MYC_22102868_ChIP-Seq_BL_Human | 1.51528922 |
| 40 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.50861233 |
| 41 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.50348806 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45487182 |
| 43 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.45345218 |
| 44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43755740 |
| 45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.43047413 |
| 46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.40141191 |
| 47 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.33215357 |
| 48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31463439 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30987449 |
| 50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30910283 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.28824822 |
| 52 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27007529 |
| 53 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.25426643 |
| 54 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.22419143 |
| 55 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.22419143 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.21846747 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.21374428 |
| 58 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.20226512 |
| 59 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20155985 |
| 60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15317009 |
| 61 | UTX_26944678_Chip-Seq_JUKART_Human | 1.15107226 |
| 62 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.13381480 |
| 63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11180192 |
| 64 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.11138730 |
| 65 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.09823114 |
| 66 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09317073 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08518517 |
| 68 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08377827 |
| 69 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07748714 |
| 70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.06585790 |
| 71 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05977903 |
| 72 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05200169 |
| 73 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04798154 |
| 74 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04779385 |
| 75 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.04525300 |
| 76 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04432015 |
| 77 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.02452054 |
| 78 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01945224 |
| 79 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01850989 |
| 80 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.01396900 |
| 81 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.01345705 |
| 82 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00910395 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00096707 |
| 84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99779238 |
| 85 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98592363 |
| 86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97365676 |
| 87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96795894 |
| 88 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.96001821 |
| 89 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.96001821 |
| 90 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.96001821 |
| 91 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94869971 |
| 92 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.94818685 |
| 93 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94278923 |
| 94 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.93828038 |
| 95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93536560 |
| 96 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93069528 |
| 97 | * MAF_26560356_Chip-Seq_TH2_Human | 0.92068316 |
| 98 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91976819 |
| 99 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91219421 |
| 100 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.90280404 |
| 101 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89434822 |
| 102 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88807472 |
| 103 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88203162 |
| 104 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.86444178 |
| 105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86303551 |
| 106 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.85227784 |
| 107 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84637531 |
| 108 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.84006707 |
| 109 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.83906655 |
| 110 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83182561 |
| 111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82867414 |
| 112 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.82204411 |
| 113 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81098422 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78625876 |
| 115 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.78592115 |
| 116 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77825885 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.76664686 |
| 118 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.76415870 |
| 119 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75274990 |
| 120 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.74357871 |
| 121 | * CLOCK_20551151_ChIP-Seq_293T_Human | 0.73474245 |
| 122 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.72443440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.26524888 |
| 2 | MP0003436_decreased_susceptibility_to | 3.49021361 |
| 3 | MP0000685_abnormal_immune_system | 3.42714444 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.37885662 |
| 5 | * MP0009785_altered_susceptibility_to | 3.36176467 |
| 6 | MP0003724_increased_susceptibility_to | 3.29734365 |
| 7 | MP0005671_abnormal_response_to | 3.10312316 |
| 8 | MP0002254_reproductive_system_inflammat | 3.08586605 |
| 9 | * MP0005000_abnormal_immune_tolerance | 3.02426720 |
| 10 | MP0005387_immune_system_phenotype | 3.01559948 |
| 11 | MP0001790_abnormal_immune_system | 3.01559948 |
| 12 | MP0004510_myositis | 2.84931477 |
| 13 | MP0003303_peritoneal_inflammation | 2.77728127 |
| 14 | * MP0001800_abnormal_humoral_immune | 2.68078836 |
| 15 | * MP0002419_abnormal_innate_immunity | 2.67110166 |
| 16 | * MP0005025_abnormal_response_to | 2.65648920 |
| 17 | * MP0002452_abnormal_antigen_presenting | 2.56788867 |
| 18 | MP0006082_CNS_inflammation | 2.50839318 |
| 19 | * MP0002723_abnormal_immune_serum | 2.49592158 |
| 20 | * MP0001819_abnormal_immune_cell | 2.24521759 |
| 21 | * MP0002420_abnormal_adaptive_immunity | 2.23156390 |
| 22 | * MP0004947_skin_inflammation | 2.17390779 |
| 23 | MP0001853_heart_inflammation | 2.14300259 |
| 24 | MP0002006_tumorigenesis | 2.12341999 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 2.11391328 |
| 26 | MP0002405_respiratory_system_inflammati | 2.07242987 |
| 27 | MP0002166_altered_tumor_susceptibility | 2.03167944 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.98507822 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.96239435 |
| 30 | MP0001873_stomach_inflammation | 1.84453088 |
| 31 | MP0003763_abnormal_thymus_physiology | 1.84071913 |
| 32 | * MP0001845_abnormal_inflammatory_respons | 1.77796879 |
| 33 | MP0005310_abnormal_salivary_gland | 1.76958977 |
| 34 | MP0009764_decreased_sensitivity_to | 1.72147746 |
| 35 | MP0003448_altered_tumor_morphology | 1.66489278 |
| 36 | * MP0000716_abnormal_immune_system | 1.61423648 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.60152874 |
| 38 | MP0009278_abnormal_bone_marrow | 1.58437004 |
| 39 | MP0003453_abnormal_keratinocyte_physiol | 1.58432941 |
| 40 | * MP0002398_abnormal_bone_marrow | 1.54417890 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.51097986 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.49313821 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 1.49053763 |
| 44 | MP0001851_eye_inflammation | 1.43893330 |
| 45 | MP0002277_abnormal_respiratory_mucosa | 1.42242841 |
| 46 | * MP0008469_abnormal_protein_level | 1.39503416 |
| 47 | MP0000343_altered_response_to | 1.39261773 |
| 48 | MP0000858_altered_metastatic_potential | 1.38228981 |
| 49 | MP0003828_pulmonary_edema | 1.34265625 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.30544567 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.29714242 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.29714242 |
| 53 | MP0001501_abnormal_sleep_pattern | 1.29520843 |
| 54 | MP0002139_abnormal_hepatobiliary_system | 1.27144554 |
| 55 | * MP0002429_abnormal_blood_cell | 1.25940778 |
| 56 | MP0003195_calcinosis | 1.25209603 |
| 57 | MP0002933_joint_inflammation | 1.23207116 |
| 58 | MP0002009_preneoplasia | 1.22233443 |
| 59 | MP0008004_abnormal_stomach_pH | 1.21581922 |
| 60 | * MP0000689_abnormal_spleen_morphology | 1.19916640 |
| 61 | * MP0002722_abnormal_immune_system | 1.19513244 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 1.17173392 |
| 63 | MP0001348_abnormal_lacrimal_gland | 1.14876169 |
| 64 | MP0003075_altered_response_to | 1.14450057 |
| 65 | MP0000604_amyloidosis | 1.10535886 |
| 66 | MP0005058_abnormal_lysosome_morphology | 1.08641211 |
| 67 | MP0005390_skeleton_phenotype | 1.06936361 |
| 68 | MP0003191_abnormal_cellular_cholesterol | 1.06595829 |
| 69 | MP0002877_abnormal_melanocyte_morpholog | 1.05049366 |
| 70 | MP0001346_abnormal_lacrimal_gland | 1.04358927 |
| 71 | MP0004782_abnormal_surfactant_physiolog | 1.03991564 |
| 72 | MP0002332_abnormal_exercise_endurance | 1.00537105 |
| 73 | MP0003172_abnormal_lysosome_physiology | 1.00422091 |
| 74 | MP0005164_abnormal_response_to | 0.97962169 |
| 75 | MP0009840_abnormal_foam_cell | 0.95823302 |
| 76 | MP0001879_abnormal_lymphatic_vessel | 0.94391506 |
| 77 | MP0005166_decreased_susceptibility_to | 0.91936966 |
| 78 | MP0004381_abnormal_hair_follicle | 0.90834707 |
| 79 | MP0010352_gastrointestinal_tract_polyps | 0.89511622 |
| 80 | MP0003866_abnormal_defecation | 0.89423139 |
| 81 | MP0000249_abnormal_blood_vessel | 0.88935194 |
| 82 | MP0009763_increased_sensitivity_to | 0.85795756 |
| 83 | * MP0000703_abnormal_thymus_morphology | 0.85715156 |
| 84 | MP0003566_abnormal_cell_adhesion | 0.85111198 |
| 85 | * MP0001216_abnormal_epidermal_layer | 0.83993597 |
| 86 | MP0002163_abnormal_gland_morphology | 0.82695298 |
| 87 | MP0003091_abnormal_cell_migration | 0.77787958 |
| 88 | MP0010234_abnormal_vibrissa_follicle | 0.77212509 |
| 89 | MP0005165_increased_susceptibility_to | 0.75801711 |
| 90 | MP0005023_abnormal_wound_healing | 0.75253189 |
| 91 | MP0002060_abnormal_skin_morphology | 0.74957869 |
| 92 | MP0000465_gastrointestinal_hemorrhage | 0.74929430 |
| 93 | MP0004808_abnormal_hematopoietic_stem | 0.73880537 |
| 94 | MP0000767_abnormal_smooth_muscle | 0.73270002 |
| 95 | MP0003045_fibrosis | 0.73122287 |
| 96 | MP0004883_abnormal_blood_vessel | 0.70231337 |
| 97 | MP0000490_abnormal_crypts_of | 0.70108629 |
| 98 | MP0001881_abnormal_mammary_gland | 0.68961343 |
| 99 | MP0003795_abnormal_bone_structure | 0.68647188 |
| 100 | MP0002396_abnormal_hematopoietic_system | 0.67763279 |
| 101 | MP0002136_abnormal_kidney_physiology | 0.66203716 |
| 102 | MP0003941_abnormal_skin_development | 0.65407986 |
| 103 | * MP0001191_abnormal_skin_condition | 0.64881944 |
| 104 | MP0002796_impaired_skin_barrier | 0.63519433 |
| 105 | MP0005451_abnormal_body_composition | 0.63417173 |
| 106 | * MP0005076_abnormal_cell_differentiation | 0.62628188 |
| 107 | MP0000609_abnormal_liver_physiology | 0.62460585 |
| 108 | MP0003183_abnormal_peptide_metabolism | 0.62411385 |
| 109 | MP0001663_abnormal_digestive_system | 0.61569080 |
| 110 | MP0001542_abnormal_bone_strength | 0.60662048 |
| 111 | MP0006054_spinal_hemorrhage | 0.60348997 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.59091129 |
| 113 | MP0003646_muscle_fatigue | 0.57878896 |
| 114 | MP0003690_abnormal_glial_cell | 0.56844196 |
| 115 | MP0003806_abnormal_nucleotide_metabolis | 0.53938327 |
| 116 | MP0005535_abnormal_body_temperature | 0.53144541 |
| 117 | MP0005319_abnormal_enzyme/_coenzyme | 0.52852558 |
| 118 | MP0005647_abnormal_sex_gland | 0.52797769 |
| 119 | MP0001919_abnormal_reproductive_system | 0.51414516 |
| 120 | MP0008874_decreased_physiological_sensi | 0.48948553 |
| 121 | MP0008875_abnormal_xenobiotic_pharmacok | 0.46732876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.15032472 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.88489672 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.53836578 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.45426477 |
| 5 | Myositis (HP:0100614) | 5.10103651 |
| 6 | Orchitis (HP:0100796) | 5.06249868 |
| 7 | Optic neuritis (HP:0100653) | 5.01745159 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 5.01745159 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.43595851 |
| 10 | Stomatitis (HP:0010280) | 4.43399374 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 4.38215767 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.38215767 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.38215767 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.13881427 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.05874123 |
| 16 | Abnormality of macrophages (HP:0004311) | 4.02314115 |
| 17 | Recurrent skin infections (HP:0001581) | 3.80576704 |
| 18 | Vasculitis (HP:0002633) | 3.77907796 |
| 19 | IgG deficiency (HP:0004315) | 3.67172279 |
| 20 | Increased IgM level (HP:0003496) | 3.63985536 |
| 21 | Autoimmune thrombocytopenia (HP:0001973) | 3.63908113 |
| 22 | Pulmonary infiltrates (HP:0002113) | 3.50782944 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.48404718 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.48404718 |
| 25 | Pustule (HP:0200039) | 3.39742490 |
| 26 | Keratoconjunctivitis (HP:0001096) | 3.36576027 |
| 27 | Recurrent viral infections (HP:0004429) | 3.32213597 |
| 28 | Chronic otitis media (HP:0000389) | 3.29814299 |
| 29 | Systemic lupus erythematosus (HP:0002725) | 3.29454318 |
| 30 | Gingivitis (HP:0000230) | 3.28139430 |
| 31 | Keratoconjunctivitis sicca (HP:0001097) | 3.19441854 |
| 32 | Dysostosis multiplex (HP:0000943) | 3.18261389 |
| 33 | Colitis (HP:0002583) | 3.06428139 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 3.03095887 |
| 35 | Obstructive lung disease (HP:0006536) | 3.03095887 |
| 36 | Leukocytosis (HP:0001974) | 3.02919048 |
| 37 | Prostate neoplasm (HP:0100787) | 3.00016407 |
| 38 | Interstitial pulmonary disease (HP:0006530) | 2.99950512 |
| 39 | Hematochezia (HP:0002573) | 2.98015365 |
| 40 | Thick nail (HP:0001805) | 2.96956477 |
| 41 | Arterial thrombosis (HP:0004420) | 2.94974811 |
| 42 | Periodontitis (HP:0000704) | 2.85399391 |
| 43 | Meningitis (HP:0001287) | 2.83810070 |
| 44 | Hemoptysis (HP:0002105) | 2.82575388 |
| 45 | Gastrointestinal infarctions (HP:0005244) | 2.82498519 |
| 46 | Increased IgE level (HP:0003212) | 2.82019750 |
| 47 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.80007775 |
| 48 | Cellulitis (HP:0100658) | 2.79128132 |
| 49 | Eosinophilia (HP:0001880) | 2.77630499 |
| 50 | Inflammation of the large intestine (HP:0002037) | 2.77622206 |
| 51 | Hypergammaglobulinemia (HP:0010702) | 2.77452709 |
| 52 | Autoimmune hemolytic anemia (HP:0001890) | 2.73659407 |
| 53 | Vacuolated lymphocytes (HP:0001922) | 2.73182574 |
| 54 | Abnormality of the nasal mucosa (HP:0000433) | 2.72789465 |
| 55 | Nasal polyposis (HP:0100582) | 2.72065478 |
| 56 | Abnormality of B cell number (HP:0010975) | 2.68841113 |
| 57 | Abnormality of T cell number (HP:0011839) | 2.65279359 |
| 58 | Increased serum ferritin (HP:0003281) | 2.62436274 |
| 59 | Loss of speech (HP:0002371) | 2.61803421 |
| 60 | Urticaria (HP:0001025) | 2.59902732 |
| 61 | Polyneuropathy (HP:0001271) | 2.56405041 |
| 62 | Recurrent bronchitis (HP:0002837) | 2.54614832 |
| 63 | Gastrointestinal inflammation (HP:0004386) | 2.53307051 |
| 64 | Spontaneous hematomas (HP:0007420) | 2.51612708 |
| 65 | Premature loss of primary teeth (HP:0006323) | 2.48791803 |
| 66 | Myocardial infarction (HP:0001658) | 2.45968785 |
| 67 | Glomerulopathy (HP:0100820) | 2.41949557 |
| 68 | Granulocytopenia (HP:0001913) | 2.41161175 |
| 69 | Gangrene (HP:0100758) | 2.40696460 |
| 70 | Basal ganglia calcification (HP:0002135) | 2.40123820 |
| 71 | Tetraparesis (HP:0002273) | 2.39823745 |
| 72 | Abnormality of eosinophils (HP:0001879) | 2.39314856 |
| 73 | Pulmonary embolism (HP:0002204) | 2.38163181 |
| 74 | Vertigo (HP:0002321) | 2.36376641 |
| 75 | Recurrent pneumonia (HP:0006532) | 2.35488728 |
| 76 | B lymphocytopenia (HP:0010976) | 2.35337648 |
| 77 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.35270145 |
| 78 | Agammaglobulinemia (HP:0004432) | 2.34002370 |
| 79 | Osteomyelitis (HP:0002754) | 2.32662322 |
| 80 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.31523405 |
| 81 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.31523405 |
| 82 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.31523405 |
| 83 | Keratitis (HP:0000491) | 2.26297034 |
| 84 | Abnormality of T cell physiology (HP:0011840) | 2.26244082 |
| 85 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.25499763 |
| 86 | Abnormality of T cells (HP:0002843) | 2.23964157 |
| 87 | Glomerulonephritis (HP:0000099) | 2.23851658 |
| 88 | Panhypogammaglobulinemia (HP:0003139) | 2.22741174 |
| 89 | Episodic fever (HP:0001954) | 2.21228692 |
| 90 | Petechiae (HP:0000967) | 2.20081976 |
| 91 | Axonal loss (HP:0003447) | 2.19334422 |
| 92 | Increased cerebral lipofuscin (HP:0011813) | 2.19306629 |
| 93 | Abnormality of iron homeostasis (HP:0011031) | 2.18800985 |
| 94 | T lymphocytopenia (HP:0005403) | 2.18709866 |
| 95 | Gingival bleeding (HP:0000225) | 2.18589224 |
| 96 | Parakeratosis (HP:0001036) | 2.17909766 |
| 97 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.15563944 |
| 98 | Mucopolysacchariduria (HP:0008155) | 2.15563944 |
| 99 | Stomach cancer (HP:0012126) | 2.14945831 |
| 100 | Emphysema (HP:0002097) | 2.14517988 |
| 101 | Skin ulcer (HP:0200042) | 2.14133059 |
| 102 | Thyroiditis (HP:0100646) | 2.13523316 |
| 103 | Amyloidosis (HP:0011034) | 2.10824375 |
| 104 | Osteolytic defects of the hand bones (HP:0009699) | 2.10558492 |
| 105 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.10558492 |
| 106 | Recurrent lower respiratory tract infections (HP:0002783) | 2.10014777 |
| 107 | Abnormality of the prostate (HP:0008775) | 2.09596687 |
| 108 | IgA deficiency (HP:0002720) | 2.09017938 |
| 109 | Abnormality of the pericardium (HP:0001697) | 2.08870132 |
| 110 | Severe combined immunodeficiency (HP:0004430) | 2.08855085 |
| 111 | Pulmonary fibrosis (HP:0002206) | 2.08308989 |
| 112 | Encephalitis (HP:0002383) | 2.07615531 |
| 113 | Chronic diarrhea (HP:0002028) | 2.06781297 |
| 114 | Restrictive lung disease (HP:0002091) | 2.06692554 |
| 115 | Gastrointestinal stroma tumor (HP:0100723) | 2.06188874 |
| 116 | Joint swelling (HP:0001386) | 2.05789177 |
| 117 | Thrombocytosis (HP:0001894) | 2.04920138 |
| 118 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.04319813 |
| 119 | Vertebral compression fractures (HP:0002953) | 2.04005700 |
| 120 | Chest pain (HP:0100749) | 2.02226777 |
| 121 | Alveolar cell carcinoma (HP:0006519) | 2.02063820 |
| 122 | Anorexia (HP:0002039) | 1.99344232 |
| 123 | Abnormality of the endocardium (HP:0004306) | 1.98485370 |
| 124 | Arthralgia (HP:0002829) | 1.97089714 |
| 125 | Sepsis (HP:0100806) | 1.95739092 |
| 126 | Combined immunodeficiency (HP:0005387) | 1.93815007 |
| 127 | Lymphopenia (HP:0001888) | 1.92669376 |
| 128 | Abnormality of the pleura (HP:0002103) | 1.91941007 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MAP3K14 | 4.30632375 |
| 2 | TYK2 | 3.49538740 |
| 3 | IRAK3 | 3.30101095 |
| 4 | TXK | 2.98144494 |
| 5 | IRAK4 | 2.97665100 |
| 6 | * IKBKB | 2.94509144 |
| 7 | * TBK1 | 2.91419989 |
| 8 | JAK3 | 2.81876693 |
| 9 | MAP4K1 | 2.65927531 |
| 10 | * IKBKE | 2.41868829 |
| 11 | RIPK4 | 2.41314644 |
| 12 | TGFBR2 | 2.13807099 |
| 13 | PIM2 | 2.12058187 |
| 14 | JAK1 | 2.09232212 |
| 15 | BLK | 2.06868752 |
| 16 | * CHUK | 2.02113791 |
| 17 | EPHB1 | 1.92185438 |
| 18 | MST4 | 1.87698143 |
| 19 | MAP3K13 | 1.75425654 |
| 20 | KIT | 1.73231576 |
| 21 | ERN1 | 1.68209151 |
| 22 | TAOK2 | 1.63550781 |
| 23 | TESK2 | 1.59947721 |
| 24 | ZAP70 | 1.52754183 |
| 25 | FGFR4 | 1.52533129 |
| 26 | BMPR2 | 1.49656441 |
| 27 | MAP3K3 | 1.48951178 |
| 28 | EPHA3 | 1.48401400 |
| 29 | CSK | 1.46982645 |
| 30 | TEC | 1.43601340 |
| 31 | TLK1 | 1.43145876 |
| 32 | PRPF4B | 1.42055080 |
| 33 | STK10 | 1.41352284 |
| 34 | PIM1 | 1.40031721 |
| 35 | BTK | 1.34467612 |
| 36 | NLK | 1.32632260 |
| 37 | ITK | 1.31902893 |
| 38 | MAPK15 | 1.27705240 |
| 39 | FGFR3 | 1.24748595 |
| 40 | SYK | 1.23663458 |
| 41 | RPS6KA4 | 1.22297222 |
| 42 | HCK | 1.21905192 |
| 43 | JAK2 | 1.12781700 |
| 44 | ADRBK2 | 1.05489402 |
| 45 | * LCK | 1.04550963 |
| 46 | MAP3K10 | 1.03768760 |
| 47 | TAOK3 | 1.02019643 |
| 48 | TAOK1 | 1.01312041 |
| 49 | CSF1R | 0.96981206 |
| 50 | IRAK1 | 0.95859464 |
| 51 | RIPK1 | 0.95689819 |
| 52 | KDR | 0.94682713 |
| 53 | MAP2K3 | 0.90216675 |
| 54 | LYN | 0.89860303 |
| 55 | MAP2K2 | 0.89082370 |
| 56 | GRK7 | 0.84765510 |
| 57 | NME2 | 0.81360728 |
| 58 | NEK9 | 0.78463351 |
| 59 | DDR2 | 0.78370188 |
| 60 | BMX | 0.77735737 |
| 61 | PTK6 | 0.77421631 |
| 62 | MAPKAPK2 | 0.76543019 |
| 63 | CLK1 | 0.71289595 |
| 64 | TGFBR1 | 0.70247826 |
| 65 | TNK2 | 0.70097278 |
| 66 | MARK3 | 0.69931892 |
| 67 | MST1R | 0.69385926 |
| 68 | CDC42BPA | 0.68407492 |
| 69 | TIE1 | 0.68267323 |
| 70 | TRPM7 | 0.66870360 |
| 71 | PBK | 0.62750187 |
| 72 | BMPR1B | 0.60742118 |
| 73 | MOS | 0.58527060 |
| 74 | SIK3 | 0.58434292 |
| 75 | LRRK2 | 0.58401341 |
| 76 | PRKCD | 0.54956329 |
| 77 | RPS6KA5 | 0.53026973 |
| 78 | MATK | 0.51630049 |
| 79 | MAP3K1 | 0.51614981 |
| 80 | PDK1 | 0.51608255 |
| 81 | MAP3K5 | 0.50173035 |
| 82 | MAP3K11 | 0.50073525 |
| 83 | FGR | 0.49606518 |
| 84 | MAP2K6 | 0.48417110 |
| 85 | PRKCQ | 0.48325257 |
| 86 | NUAK1 | 0.48228332 |
| 87 | GSK3A | 0.47360534 |
| 88 | * ABL1 | 0.47315859 |
| 89 | RPS6KA6 | 0.47128984 |
| 90 | CDK4 | 0.46175904 |
| 91 | CAMKK2 | 0.46132761 |
| 92 | FES | 0.45397184 |
| 93 | YES1 | 0.44633984 |
| 94 | MAPK11 | 0.43951340 |
| 95 | ABL2 | 0.43412143 |
| 96 | STK24 | 0.42514275 |
| 97 | CDK9 | 0.41484817 |
| 98 | CDK6 | 0.39951322 |
| 99 | DYRK1B | 0.39703857 |
| 100 | MAPK7 | 0.39057903 |
| 101 | RPS6KA2 | 0.37757387 |
| 102 | MAPK4 | 0.36968914 |
| 103 | GRK6 | 0.34344449 |
| 104 | FLT3 | 0.34332457 |
| 105 | NEK6 | 0.33164035 |
| 106 | PKN1 | 0.32838042 |
| 107 | HIPK2 | 0.32768630 |
| 108 | * EGFR | 0.32572980 |
| 109 | IGF1R | 0.31102005 |
| 110 | PDGFRB | 0.30110388 |
| 111 | MAPK3 | 0.29388543 |
| 112 | RPS6KL1 | 0.28995797 |
| 113 | RPS6KC1 | 0.28995797 |
| 114 | MAPKAPK3 | 0.28641414 |
| 115 | FYN | 0.27961573 |
| 116 | PRKG2 | 0.27650944 |
| 117 | SIK2 | 0.27160449 |
| 118 | MAP2K1 | 0.26998731 |
| 119 | PDPK1 | 0.26738069 |
| 120 | IRAK2 | 0.26127552 |
| 121 | FRK | 0.25936401 |
| 122 | ARAF | 0.25707226 |
| 123 | DAPK2 | 0.25166535 |
| 124 | * INSR | 0.24949047 |
| 125 | MAPK12 | 0.24310872 |
| 126 | BCKDK | 0.21039442 |
| 127 | ZAK | 0.19545303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.41981964 |
| 2 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.09644794 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.09346843 |
| 4 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.09136000 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.77269991 |
| 6 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.51031834 |
| 7 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.44226623 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.43824194 |
| 9 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.39474295 |
| 10 | Malaria_Homo sapiens_hsa05144 | 2.30947263 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.29798734 |
| 12 | * TNF signaling pathway_Homo sapiens_hsa04668 | 2.23446853 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 2.19172413 |
| 14 | * Legionellosis_Homo sapiens_hsa05134 | 2.18796490 |
| 15 | * Measles_Homo sapiens_hsa05162 | 2.16375017 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.01183699 |
| 17 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.00154876 |
| 18 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.97566460 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.92438789 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.87810836 |
| 21 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.85435552 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.84668717 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.80499132 |
| 24 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.79650348 |
| 25 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.79323602 |
| 26 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.78843466 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.75307635 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.71605419 |
| 29 | * Influenza A_Homo sapiens_hsa05164 | 1.70193298 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.68457359 |
| 31 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.55672946 |
| 32 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.51376067 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.49862573 |
| 34 | * Apoptosis_Homo sapiens_hsa04210 | 1.49701161 |
| 35 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45284674 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.43836285 |
| 37 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.34393865 |
| 38 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30369283 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.24998695 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.13599271 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.10587990 |
| 42 | * Hepatitis C_Homo sapiens_hsa05160 | 1.05354187 |
| 43 | * Hepatitis B_Homo sapiens_hsa05161 | 1.04300689 |
| 44 | * Shigellosis_Homo sapiens_hsa05131 | 1.03561683 |
| 45 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.99710716 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.94364866 |
| 47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92976079 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 0.89982024 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 0.87158618 |
| 50 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86568534 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 0.86546958 |
| 52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.80086843 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.79363265 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.76707587 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.76270935 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71646481 |
| 57 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.68209148 |
| 58 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67941448 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62953603 |
| 60 | * Small cell lung cancer_Homo sapiens_hsa05222 | 0.60656514 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.59847073 |
| 62 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59072106 |
| 63 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.58432263 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58391317 |
| 65 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.57001840 |
| 66 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56346876 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54795019 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54633644 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.53651124 |
| 70 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51436871 |
| 71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49465511 |
| 72 | Bladder cancer_Homo sapiens_hsa05219 | 0.42056991 |
| 73 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41943134 |
| 74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40733384 |
| 75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.40616646 |
| 76 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39803235 |
| 77 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38916415 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38453520 |
| 79 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38159804 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37579651 |
| 81 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.36105108 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35231835 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34784960 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34543695 |
| 85 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.33482038 |
| 86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32606625 |
| 87 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31542106 |
| 88 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.30240595 |
| 89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.28871666 |
| 90 | Adherens junction_Homo sapiens_hsa04520 | 0.28853157 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27883601 |
| 92 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.26813255 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25415963 |
| 94 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25081976 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24655421 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.24596985 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.24502386 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24356321 |
| 99 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.22561398 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.22518430 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.22280743 |
| 102 | * Insulin resistance_Homo sapiens_hsa04931 | 0.21452168 |
| 103 | Focal adhesion_Homo sapiens_hsa04510 | 0.19150100 |
| 104 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.17666783 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.16718406 |
| 106 | Mineral absorption_Homo sapiens_hsa04978 | 0.15758511 |
| 107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.14208402 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.12051888 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.12036236 |
| 110 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.11810380 |
| 111 | Circadian rhythm_Homo sapiens_hsa04710 | 0.07316590 |
| 112 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.06549026 |
| 113 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.05488402 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.04176071 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.03691417 |

